Cardiovascular Disease & Diabetes Statistics in Korea: Nationwide Data 2010 to 2019
Background This study aimed to provide updated insights into the incidence and management of cardiovascular disease (CVD) in Korean adults with diabetes. Methods Using data from the Korean National Health Insurance Service and Korea National Health and Nutrition Examination Survey, we analyzed the r...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Korean Diabetes Association
2024-11-01
|
| Series: | Diabetes & Metabolism Journal |
| Subjects: | |
| Online Access: | http://e-dmj.org/upload/pdf/dmj-2024-0275.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846150006169403392 |
|---|---|
| author | Jin Hwa Kim Junyeop Lee Kyungdo Han Jae-Taek Kim Hyuk-Sang Kwon on Behalf of the Diabetic Vascular Disease Research Group of the Korean Diabetes Association |
| author_facet | Jin Hwa Kim Junyeop Lee Kyungdo Han Jae-Taek Kim Hyuk-Sang Kwon on Behalf of the Diabetic Vascular Disease Research Group of the Korean Diabetes Association |
| author_sort | Jin Hwa Kim |
| collection | DOAJ |
| description | Background This study aimed to provide updated insights into the incidence and management of cardiovascular disease (CVD) in Korean adults with diabetes. Methods Using data from the Korean National Health Insurance Service and Korea National Health and Nutrition Examination Survey, we analyzed the representative national estimates of CVD in adults with diabetes. Results The age- and sex-standardized incidence rate of ischemic heart disease (IHD), ischemic stroke, and peripheral artery disease (PAD) decreased from 2010 to 2019 in individuals with type 2 diabetes mellitus (T2DM). However, an increase in the incidence of heart failure (HF) was observed during the same period. Only 4.96% of adults with diabetes and CVD achieved optimal control of all three risk factors (glycemic levels, blood pressure, and lipid control). Additionally, high-intensity statin treatment rates were 8.84% and 9.15% in individuals with IHD and ischemic stroke, respectively. Treatment with a sodium-glucose cotransporter-2 inhibitor (SGLT2i) or a glucagon-like peptide-1 receptor agonist (GLP-1RA) was relatively low in 2019, with only 11.87%, 7.10%, and 11.05% of individuals with IHD, ischemic stroke, and HF, respectively, receiving SGLT2i treatment. Furthermore, only 1.08%, 0.79%, and 1.06% of patients with IHD, ischemic stroke, and HF, respectively, were treated with GLP-1RA. Conclusion The incidence of most CVD (IHD, ischemic stroke, and PAD) decreased between 2010 and 2019, whereas the incidence of HF increased. The overall use of high-intensity statins, SGLT2i, and GLP-1RA remained low among individuals with T2DM and CVD. |
| format | Article |
| id | doaj-art-0851c5a27ec44c0e8e093f9a4b81c307 |
| institution | Kabale University |
| issn | 2233-6079 2233-6087 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | Korean Diabetes Association |
| record_format | Article |
| series | Diabetes & Metabolism Journal |
| spelling | doaj-art-0851c5a27ec44c0e8e093f9a4b81c3072024-11-29T06:51:01ZengKorean Diabetes AssociationDiabetes & Metabolism Journal2233-60792233-60872024-11-014861084109210.4093/dmj.2024.02752900Cardiovascular Disease & Diabetes Statistics in Korea: Nationwide Data 2010 to 2019Jin Hwa Kim0Junyeop Lee1Kyungdo Han2Jae-Taek Kim3Hyuk-Sang Kwon4on Behalf of the Diabetic Vascular Disease Research Group of the Korean Diabetes Association Department of Endocrinology and Metabolism, Chosun University Hospital, Chosun University College of Medicine, Gwangju, Korea Department of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Department of Statistics and Actuarial Science, Soongsil University, Seoul, Korea Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea Division of Endocrinology and Metabolism, Department of Internal Medicine, Yeouido St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, KoreaBackground This study aimed to provide updated insights into the incidence and management of cardiovascular disease (CVD) in Korean adults with diabetes. Methods Using data from the Korean National Health Insurance Service and Korea National Health and Nutrition Examination Survey, we analyzed the representative national estimates of CVD in adults with diabetes. Results The age- and sex-standardized incidence rate of ischemic heart disease (IHD), ischemic stroke, and peripheral artery disease (PAD) decreased from 2010 to 2019 in individuals with type 2 diabetes mellitus (T2DM). However, an increase in the incidence of heart failure (HF) was observed during the same period. Only 4.96% of adults with diabetes and CVD achieved optimal control of all three risk factors (glycemic levels, blood pressure, and lipid control). Additionally, high-intensity statin treatment rates were 8.84% and 9.15% in individuals with IHD and ischemic stroke, respectively. Treatment with a sodium-glucose cotransporter-2 inhibitor (SGLT2i) or a glucagon-like peptide-1 receptor agonist (GLP-1RA) was relatively low in 2019, with only 11.87%, 7.10%, and 11.05% of individuals with IHD, ischemic stroke, and HF, respectively, receiving SGLT2i treatment. Furthermore, only 1.08%, 0.79%, and 1.06% of patients with IHD, ischemic stroke, and HF, respectively, were treated with GLP-1RA. Conclusion The incidence of most CVD (IHD, ischemic stroke, and PAD) decreased between 2010 and 2019, whereas the incidence of HF increased. The overall use of high-intensity statins, SGLT2i, and GLP-1RA remained low among individuals with T2DM and CVD.http://e-dmj.org/upload/pdf/dmj-2024-0275.pdfcardiovascular diseasesdiabetes mellitusepidemiologykorea |
| spellingShingle | Jin Hwa Kim Junyeop Lee Kyungdo Han Jae-Taek Kim Hyuk-Sang Kwon on Behalf of the Diabetic Vascular Disease Research Group of the Korean Diabetes Association Cardiovascular Disease & Diabetes Statistics in Korea: Nationwide Data 2010 to 2019 Diabetes & Metabolism Journal cardiovascular diseases diabetes mellitus epidemiology korea |
| title | Cardiovascular Disease & Diabetes Statistics in Korea: Nationwide Data 2010 to 2019 |
| title_full | Cardiovascular Disease & Diabetes Statistics in Korea: Nationwide Data 2010 to 2019 |
| title_fullStr | Cardiovascular Disease & Diabetes Statistics in Korea: Nationwide Data 2010 to 2019 |
| title_full_unstemmed | Cardiovascular Disease & Diabetes Statistics in Korea: Nationwide Data 2010 to 2019 |
| title_short | Cardiovascular Disease & Diabetes Statistics in Korea: Nationwide Data 2010 to 2019 |
| title_sort | cardiovascular disease diabetes statistics in korea nationwide data 2010 to 2019 |
| topic | cardiovascular diseases diabetes mellitus epidemiology korea |
| url | http://e-dmj.org/upload/pdf/dmj-2024-0275.pdf |
| work_keys_str_mv | AT jinhwakim cardiovasculardiseasediabetesstatisticsinkoreanationwidedata2010to2019 AT junyeoplee cardiovasculardiseasediabetesstatisticsinkoreanationwidedata2010to2019 AT kyungdohan cardiovasculardiseasediabetesstatisticsinkoreanationwidedata2010to2019 AT jaetaekkim cardiovasculardiseasediabetesstatisticsinkoreanationwidedata2010to2019 AT hyuksangkwon cardiovasculardiseasediabetesstatisticsinkoreanationwidedata2010to2019 AT onbehalfofthediabeticvasculardiseaseresearchgroupofthekoreandiabetesassociation cardiovasculardiseasediabetesstatisticsinkoreanationwidedata2010to2019 |